Title: Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial
Authors: Kereiakes, Dean J ×
Meredith, Ian T
Windecker, Stephan
Lee Jobe, R
Mehta, Shamir R
Sarembock, Ian J
Feldman, Robert L
Stein, Bernardo
Dubois, Christophe
Grady, Timothy
Saito, Shigeru
Kimura, Takeshi
Christen, Thomas
Allocco, Dominic J
Dawkins, Keith D #
Issue Date: Apr-2015
Series Title: Circulation-Cardiovascular Interventions vol:8 issue:4
Article number: 10.1161/CIRCINTERVENTIONS.114.002372
Abstract: Drug eluting stents with durable polymers may be associated with hypersensitivity, delayed healing, and incomplete endothelialization, which may contribute to late/very late stent thrombosis and the need for prolonged dual antiplatelet therapy. Bioabsorbable polymers may facilitate stent healing, thus enhancing clinical safety. The SYNERGY stent is a thin-strut, platinum chromium metal alloy platform with an ultrathin bioabsorbable Poly(D,L-lactide-co-glycolide) abluminal everolimus-eluting polymer. We performed a multicenter, randomized controlled trial for regulatory approval to determine noninferiority of the SYNERGY stent to the durable polymer PROMUS Element Plus everolimus-eluting stent.
ISSN: 1941-7640
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Cardiology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science